Anupam Rasayan IPO - Valuations Exceed Growth Prospects: Reliance Securities 
An employee prepares a solution in a flask during a test. (Photographer Brent Lewin/Bloomberg)

Anupam Rasayan IPO - Valuations Exceed Growth Prospects: Reliance Securities 

BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.

Reliance Securities Report

Anupam Rasayan India Ltd. is one of the leading companies engaged in the custom synthesis and manufacturing of specialty chemicals in India.

It commenced business as a partnership firm in 1984 as a manufacturer of conventional products.

Over the years, it has evolved into custom synthesis and manufacturing of life science-related specialty chemicals and other specialty chemicals, which involve multi-step synthesis and complex technologies, for a diverse base of Indian and global customers.

The company has two distinct business verticals;

1. life science-related specialty chemicals comprising products related to agrochemicals, personal care and pharmaceuticals, and

2. other specialty chemicals, comprising of specialty pigment, dyes, and polymer additives.

Click on the attachment to read the full report:

Reliance Securities Anupam Rasayan India Ltd. IPO Note.pdf


This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BloombergQuint.

Users have no license to copy, modify, or distribute the content without permission of the Original Owner.

BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.